Evotec Says Sandoz Deal Is ‘Validation’ Of Biologics Ambitions

Chief Business Officer Matthias Evers Talks Biologics Technology Platform And Access

 
• By David Wallace
Matthias Evers, Evotec’s chief business officer
Matthias Evers is Evotec’s chief business officer • Source: Evotec

More from Strategy

More from Business